vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $48.4M, roughly 1.6× First Foundation Inc.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -97.9%, a 105.3% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 25.5%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-35.2M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -2.7%).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
FFWM vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $76.2M |
| Net Profit | $-8.0M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | -97.5% | 11.0% |
| Net Margin | -97.9% | 7.4% |
| Revenue YoY | 421.7% | 25.5% |
| Net Profit YoY | 43.0% | 30.7% |
| EPS (diluted) | $-0.09 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $76.2M | ||
| Q3 25 | $63.6M | $71.9M | ||
| Q2 25 | $51.4M | $63.1M | ||
| Q1 25 | $71.4M | $59.1M | ||
| Q4 24 | $9.3M | $60.7M | ||
| Q3 24 | $9.2M | $58.0M | ||
| Q2 24 | $57.5M | $55.0M | ||
| Q1 24 | $51.1M | $50.6M |
| Q4 25 | $-8.0M | $5.6M | ||
| Q3 25 | $-146.3M | $3.5M | ||
| Q2 25 | $-7.7M | $3.2M | ||
| Q1 25 | $6.9M | $2.6M | ||
| Q4 24 | $-14.1M | $4.3M | ||
| Q3 24 | $-82.2M | $3.9M | ||
| Q2 24 | $3.1M | $1.5M | ||
| Q1 24 | $793.0K | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -97.5% | 11.0% | ||
| Q3 25 | -92.7% | 7.8% | ||
| Q2 25 | -21.1% | 8.1% | ||
| Q1 25 | 8.8% | 6.5% | ||
| Q4 24 | -247.7% | 10.6% | ||
| Q3 24 | -1276.7% | 9.7% | ||
| Q2 24 | 4.6% | 6.6% | ||
| Q1 24 | -0.2% | 4.4% |
| Q4 25 | -97.9% | 7.4% | ||
| Q3 25 | -230.1% | 4.9% | ||
| Q2 25 | -15.0% | 5.0% | ||
| Q1 25 | 9.7% | 4.4% | ||
| Q4 24 | -152.2% | 7.1% | ||
| Q3 24 | -896.9% | 6.7% | ||
| Q2 24 | 5.4% | 2.7% | ||
| Q1 24 | 1.6% | 3.2% |
| Q4 25 | $-0.09 | $0.14 | ||
| Q3 25 | $-1.78 | $0.09 | ||
| Q2 25 | $-0.09 | $0.08 | ||
| Q1 25 | $0.08 | $0.06 | ||
| Q4 24 | $-0.24 | $0.10 | ||
| Q3 24 | $-1.23 | $0.10 | ||
| Q2 24 | $0.05 | $0.04 | ||
| Q1 24 | $0.01 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $912.6M | $141.5M |
| Total Assets | $11.9B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | $13.5M | ||
| Q3 25 | $1.7B | $11.1M | ||
| Q2 25 | $1.1B | $20.0M | ||
| Q1 25 | $1.0B | $10.2M | ||
| Q4 24 | $1.0B | $17.5M | ||
| Q3 24 | $1.1B | $11.3M | ||
| Q2 24 | $1.4B | $8.8M | ||
| Q1 24 | $1.6B | $7.3M |
| Q4 25 | $912.6M | $141.5M | ||
| Q3 25 | $917.9M | $133.6M | ||
| Q2 25 | $1.1B | $139.7M | ||
| Q1 25 | $1.1B | $134.8M | ||
| Q4 24 | $1.1B | $131.4M | ||
| Q3 24 | $1.1B | $125.0M | ||
| Q2 24 | $933.2M | $119.4M | ||
| Q1 24 | $928.7M | $116.3M |
| Q4 25 | $11.9B | $199.2M | ||
| Q3 25 | $11.9B | $202.4M | ||
| Q2 25 | $11.6B | $184.6M | ||
| Q1 25 | $12.6B | $178.1M | ||
| Q4 24 | $12.6B | $177.1M | ||
| Q3 24 | $13.4B | $169.5M | ||
| Q2 24 | $13.7B | $163.9M | ||
| Q1 24 | $13.6B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $18.4M |
| Free Cash FlowOCF − Capex | $-35.2M | $9.7M |
| FCF MarginFCF / Revenue | -72.8% | 12.7% |
| Capex IntensityCapex / Revenue | 6.9% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | $18.4M | ||
| Q3 25 | $9.2M | $18.4M | ||
| Q2 25 | $-16.3M | $12.3M | ||
| Q1 25 | $-552.0K | $2.9M | ||
| Q4 24 | $-8.7M | $15.0M | ||
| Q3 24 | $14.2M | $12.7M | ||
| Q2 24 | $-9.1M | $10.2M | ||
| Q1 24 | $7.2M | $1.2M |
| Q4 25 | $-35.2M | $9.7M | ||
| Q3 25 | $8.6M | $10.7M | ||
| Q2 25 | $-16.7M | $4.1M | ||
| Q1 25 | $-2.5M | $-12.6M | ||
| Q4 24 | $-11.4M | $3.2M | ||
| Q3 24 | $13.4M | $1.7M | ||
| Q2 24 | $-9.4M | $1.2M | ||
| Q1 24 | $5.9M | $-4.8M |
| Q4 25 | -72.8% | 12.7% | ||
| Q3 25 | 13.5% | 14.9% | ||
| Q2 25 | -32.4% | 6.5% | ||
| Q1 25 | -3.5% | -21.4% | ||
| Q4 24 | -123.5% | 5.2% | ||
| Q3 24 | 146.2% | 3.0% | ||
| Q2 24 | -16.3% | 2.3% | ||
| Q1 24 | 11.6% | -9.5% |
| Q4 25 | 6.9% | 11.5% | ||
| Q3 25 | 1.0% | 10.6% | ||
| Q2 25 | 0.8% | 12.9% | ||
| Q1 25 | 2.8% | 26.2% | ||
| Q4 24 | 29.4% | 19.5% | ||
| Q3 24 | 9.0% | 19.0% | ||
| Q2 24 | 0.4% | 16.3% | ||
| Q1 24 | 2.5% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | -0.08× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | -2.96× | 6.94× | ||
| Q1 24 | 9.09× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
